Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice
about
sameAs
Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetesGenetics of lipid traits and relationship to coronary artery diseaseApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThe human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response elementApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?Thyroid hormone regulates the hypotriglyceridemic gene APOA5Clofibrate causes an upregulation of PPAR-{alpha} target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs.The C terminus of apolipoprotein A-V modulates lipid-binding activity.Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.Influences of APOA5 variants on plasma triglyceride levels in Uyghur populationAPOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.Genetic determinants of plasma triglyceridesZnf202 affects high density lipoprotein cholesterol levels and promotes hepatosteatosis in hyperlipidemic mice.ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.Association of the Apolipoprotein A5 Gene -1131T>C Polymorphism with Serum Lipids in Korean Subjects: Impact of Sasang Constitution.Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula miceAssociation of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery diseaseGene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategiesInfluence of apolipoprotein A-V on hepatocyte lipid droplet formationDeterminants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyUnraveling the complex genetics of familial combined hyperlipidemia.Lipoprotein metabolism in nonalcoholic fatty liver diseaseGrape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver.Identification and characterization of cyclic AMP response element-binding protein H response element in the human apolipoprotein A5 gene promoter.An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site.Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.Apolipoprotein A-V association with intracellular lipid droplets.Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
P2860
Q24791712-4F0B22FD-FE49-4DEC-9E51-4D0E0B1E7FA1Q26995252-E0740A31-90A3-42E6-AF13-2888D64AA047Q28183207-21C3938B-0CD6-49E9-A88F-970B35A4DF96Q28199120-EE7A257F-ACAB-459A-8C02-66992F3CADF0Q28256394-0C0AFEDE-4B55-497C-B548-9437AAB939DAQ28275573-759589D7-EEFA-478B-8510-6C4BC8BF07A0Q28294769-88EB66A4-2765-4D3B-BB48-D78A6CE1B1EAQ28569807-EE4982C9-AA70-49DD-BA4E-BF29500CC67EQ30319871-2C7A66E0-CF9B-48A3-8A3A-629DFDA9E0EEQ30360807-812443CC-F03C-446E-A3DA-10C47C7E8C78Q33293923-AE62A579-44B8-4DBD-A50A-FDD89A08870EQ33772642-3B1B6176-C8E3-4E47-8F8E-97553E3F98D9Q33823946-74D71B8C-8EC7-4261-86DA-743B5AB5AD9AQ33851689-89FF230E-4322-49BB-A584-5577B8B34EE3Q34048473-7917E51C-BCEA-4669-8C6A-800CCEF31334Q34332478-1BAD2568-CB4A-4F49-819B-1860C583710DQ34338496-3DD1ADF2-95BE-41F7-B010-7632626C878CQ34476810-E7A71A26-3FCC-4A16-9359-80BB280A39A0Q34503333-63BB337F-1E55-4661-88A6-0DDA2D85967FQ34612131-6F2BDC85-9152-4699-8969-833B259C78FEQ35120896-F07919AB-DE18-4F0C-A159-DE5B03FC947DQ35167954-5434CDEF-1025-47DE-83CD-6F4A3C8A7343Q35274124-B4B4C7FF-C7FB-4851-98CA-E20B82F3B1DAQ35591965-5D6E8A81-D72C-4E5A-99ED-B6B2B0054D79Q35592272-5F2E1EC7-12B3-4DD0-88CC-A8873C44522FQ35596411-9BFA1A15-0656-4FA0-BD6C-F63CA37A19D7Q35884548-EF3DB73A-5601-49C9-BD4E-CBC88C59ED22Q36382853-51AD7497-1CA0-4F7C-A60F-D8E51EC55FE3Q36496770-958862C8-8B54-424D-9542-C370B2930D83Q36558367-E0CE82E6-8C27-4E12-9D94-454312D468F8Q36580345-729CD9C6-CA0C-43A3-A588-CAB231E2E911Q36682138-78BED491-A544-4A2F-9272-063A04081EBBQ36833239-7C191B1B-AE12-46C9-802D-4FCAD97B2782Q37061267-6B865A88-CB47-4A64-8488-6EF2104ACB4AQ37441091-1B349178-62C0-4DAB-937A-EB33B7C1C6BAQ37615850-4B540944-0656-4933-802B-29177F2179B6Q38212276-A87515EC-5A44-48A9-9186-ED2F33B47C6CQ40140841-4981D297-57ED-4442-AD97-4F667244CAE8Q40316899-E7EA6AEF-FD6D-4A74-8D52-5CEDC83CA8A0Q40524290-AB4E17B3-CD38-4BEB-8B7E-87E1345F07DE
P2860
Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adenoviral overexpression of a ...... erides and cholesterol in mice
@ast
Adenoviral overexpression of a ...... erides and cholesterol in mice
@en
Adenoviral overexpression of a ...... erides and cholesterol in mice
@nl
type
label
Adenoviral overexpression of a ...... erides and cholesterol in mice
@ast
Adenoviral overexpression of a ...... erides and cholesterol in mice
@en
Adenoviral overexpression of a ...... erides and cholesterol in mice
@nl
prefLabel
Adenoviral overexpression of a ...... erides and cholesterol in mice
@ast
Adenoviral overexpression of a ...... erides and cholesterol in mice
@en
Adenoviral overexpression of a ...... erides and cholesterol in mice
@nl
P2093
P921
P3181
P1476
Adenoviral overexpression of a ...... erides and cholesterol in mice
@en
P2093
Albert K Groen
Frank G Schaap
Hendrik N van der Vliet
Johannes H M Levels
John G Wesseling
Norbert Looije
Robert A F M Chamuleau
Roelof Ottenhoff
P304
P3181
P356
10.1016/S0006-291X(02)00808-2
P407
P577
2002-08-02T00:00:00Z